WED-102-YI Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy
Francesco Vitiello(Vita-Salute San Raffaele University), Rita Balsano(Humanitas University), Silvia Camera(Vita-Salute San Raffaele University), Tiziana Pressiani(IRCCS Humanitas Research Hospital), Guido Giordano(University of Foggia), Monica Verrico(Policlinico Umberto I), Oluseyi Abidoye(Mayo Clinic), Francesca Salani(Scuola Superiore Sant'Anna), Emiliano Tamburini(Ospedale Infermi di Rimini), Margherita Rimini(Vita-Salute San Raffaele University), Masafumi Ikeda(National Cancer Center Hospital East), Anna Saborowski(Medizinische Hochschule Hannover), Alessandro Pastorino(Ospedale Policlinico San Martino), Fabian Finkelmeier(Goethe University Frankfurt), Federica Lo Prinzi(Campus Bio Medico University Hospital), Jin Wonkim, Alessandro Parisi(Marche Polytechnic University), Mario Scartozzi(University of Cagliari), Gerald W. Prager(Comprehensive Cancer Center Vienna), Ricardo Roque, Giovanni Farinea(University of Turin), Caterina Vivaldi(Scuola Superiore Sant'Anna), Gian Paolo Spinelli(Sapienza University of Rome), Chiara Braconi(Beatson West of Scotland Cancer Centre), Marta Schirripa(Azienda Sanitaria Locale Viterbo), Anna Diana(University of Campania "Luigi Vanvitelli"), Jessica Lucchetti(Campus Bio Medico University Hospital), Jorge Adeva(Hospital Universitario 12 De Octubre), Cecilia Moreira, Monica Niger(Fondazione IRCCS Istituto Nazionale dei Tumori), Nicola Personeni(IRCCS Humanitas Research Hospital), Federico Rossari(Vita-Salute San Raffaele University), Hong Jae Chon(CHA University Bundang Medical Center), Chiara Gallio(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Ingrid Garajová(University of Parma), Daniele Lavacchi(University of Florence), Jeroen Dekervel(Universitair Ziekenhuis Leuven), Chiara Pircher(Fondazione IRCCS Istituto Nazionale dei Tumori), Tomoyuki Satake(National Cancer Center Hospital East), Ilario Raposelli, Virginia Genovesi(Humanitas University), Antonio Avallone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Changhoon Yoo(Ulsan College), Stephen Chan, Antonio De Rosa(Istituto Oncologico Veneto), Mario Domenico Rizzato(Istituto Oncologico Veneto), Silvana Leo(Ospedale Vito Fazzi), Nuno Couto(Champalimaud Foundation), Kim Il Hwan, Lorenzo Antonuzzo(Azienda Ospedaliero-Universitaria Careggi)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k